Jaya Biosciences is a privately held pre-clinical stage life sciences company developing therapies for genetically defined neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and frontotemporal dementia.

Jaya Biosciences

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. Their lead compounds aim to correct progranulin deficiency and lysosomal dysfunction in GRN-related frontotemporal dementia (FTD-GRN), a genetically-defined subtype of frontotemporal dementia caused by an autosomal dominant mutation in the GRN gene.

Duane Burnett

Gerhard Koenig

Arkuda Therapeutics

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Champions Oncology, Inc.

Tekno Valves is a leading manufacturer of high pressure gas cylinder valves for Industrial, Medical, Specialty, Firefighting, CNG, SCBA, Refrigerants & Corrosive gases. Established in 1971, Tekno Valves is proudly family-owned, with the first and second-generation working with a shared vision to put Indian gas equipment at the global centre stage. With long-term and sustainable decision-making at the core of all activities, our journey of 51 years has led to Tekno Valves being accepted and used in 65+ countries worldwide. Our integrated manufacturing facility based in Kolkata, India, is equipped with the latest technology and inclusive of a tool & die shop, forging unit & ISO 17025-certified laboratories in the field of calibration, mechanical & chemical testing. The infrastructure is sustainably designed to minimize environmental impact. Cylinder valves are designed, certified, and manufactured to exceed the requirements of national & international standards. Valves bear Pi, Rho and CGA V-9 marks for exports and are approved by Federal Institute for Materials Research & Testing (BAM), Germany and Arrowhead UK. Through active participation, we contribute towards the development of technical standards in the International Organization for Standardization (ISO) / Compressed Gas Association (CGA) / Chlorine Institute (CI) / Bureau of Indian Standards (BIS) cylinder valve committees. Our association with the gas industry includes membership in IOMA, CGA, GAWDA, CI, ASTM & AIIGMA. Tekno Valves North America is accepted in Independent Welding Distributors Cooperative (IWDC) & its subsidiary PurityPlus. “Tekno” is synonymous with safety in handling high pressure, and our dedicated team of valve experts remain committed to delivering reliable valving solutions to our customers.

Metric
Company Name	Jaya Biosciences	Arkuda Therapeutics	Champions Oncology, Inc.	Tekno Valves
Symbol			CSBR
MSH ID	COM:JAYABIO	COM:ARKUDATX	COM:CHAMPIONSONCOLOGY	COM:TEKNOVALVES
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Capital Goods & Industrials
Industry	Biotechnology	Biotechnology	Biotechnology	Manufacturing
Country	US	US	US	IN
Stage		Series B
Employee Count		28	230	50
Website	jayabio.com	arkudatx.com	championsoncology.com	teknovalves.com
LinkedIn		arkudatx		tekno-valves
Founders

Metric
Market Cap		69.87M
Enterprise Value
Monthly Web Traffic	66
Web Traffic Growth	-0.95
Valuation
Raised Capital	64M

Metric
Revenue			50.16M
Revenue (LTM)
Revenue (NTM)
Gross Profit			20.75M
EBITDA			-5.05M
Operating Income			-6.92M
Net Income			-7.28M
EPS			-0.54
Diluted EPS			-0.54
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.44
Operating Profit Margin			-0.06
EBITDA Margin			-0.10
Net Profit Margin			-0.07
Return on Equity			18.61
Return on Assets			-0.14
Return on Capital Employed			-0.53

JAYA

COM:JAYABIO

Jaya Biosciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-8.40
P/B Ratio			870.78
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			1.93
EV Multiple			-10.87

Metric
Days Sales Outstanding			56.41
Days Payables Outstanding			56.43
Days Inventory Outstanding			0.00
Operating Cycle			96.17
Cash Conversion Cycle			87.69
Asset Turnover			2.07

Metric
Operating Cash Flow			-6.14M
Free Cash Flow			-6.97M
Cash Flow to Debt			-0.26
Operating Cash Flow/Sales			-0.04
Free Cash Flow Yield			-0.06

Metric
Cash & Equivalents			2.62M
Accounts Receivable			-1.99M
Inventory
Goodwill			335K
Debt to Capitalization			1.36
Debt to Assets			0.28
Current Ratio			0.67
Quick Ratio			0.69

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.02
R&D to Revenue			0.23
SG&A to Revenue			0.22